ZURICH and WASHININGTON, DC—Burson-Marsteller has launched a new subsidiary, Consitor, staffed with scientists, clinicians, marketers, branding specialists and public health experts and focused on helping healthcare clients develop integrated communication strategies targeting critical stakeholders in the healthcare and science communities.
Consitor has offices in Zurich, Switzerland under the leadership of Toula Stoffel (pictured) and Washington, DC, under the leadership of Reyn Archer.
The firm will provide support in strategy development, brand life cycle management, key opinion leader development, scientific communications, health economics, policy, advocacy and market access and will work on business issues that impact clients at both the corporate level and the product level.
“Consitor’s strategic approach rests on linking three critical elements, namely science, medicine and health,” said Consitor President Stoffel. “Showing the link between these elements will serve to drive the development of a winning strategy.”
Stoffel has been leading Burson-Marsteller’s EMEA healthcare practice since 2009. Before joining Burson-Marsteller in 2008, she was vice president and scientific director at Sudler & Hennessey in New York, focusing on the areas of oncology, neurology and metabolics. She has a medical background and is a former assistant professor of laboratory for cancer biology at Rockefeller University in New York.
Archer is a managing director and chief medical officer in Burson-Marsteller’s US healthcare practice, where he supports public health, health policy and health system regulation communications programs. Earlier in his career, Archer served as commissioner of the Texas Department of Health, where he oversaw 118 public health programs.